🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Flotufolastat F-18

Found 21 matching trials

A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults

PHASE1

Flotufolastat F-18 Injection is a positron emission tomography (PET) imagin...

Status

Recruiting

Location

Chinese PLA General Hospital

Start Date

2025-06-07

Trial ID

NCT07149831

Treatments Being Tested

Flotufolastat F-18 Injection

Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC

PHASE1

The purpose of this trial is to learn more about the effects of AAA602 and ...

Status

Withdrawn

Location

Multiple Locations

Start Date

2026-06-29

Trial ID

NCT06881823

Treatments Being Tested

AAA602 AAA802 Gallium (68Ga) gozetotide Piflufolastat (18F)Flotufolastat F 18 18F-PSMA-1007

Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Prostate Cancer

The goal of this clinical trial is to evaluate the diagnostic performance a...

Status

Recruiting

Location

Chinese PLA General Hospital

Start Date

2025-03-14

Trial ID

NCT07115277

Treatments Being Tested

Flotufolastat F-18 Injection

Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial

PHASE2

This phase II trial studies how well a short course of androgen deprivation...

Status

Recruiting

Location

Mayo Clinic in Arizona

Start Date

2025-08-25

Trial ID

NCT07025369

Treatments Being Tested

Biospecimen Collection Computed Tomography Flotufolastat F-18 Gallium Laparoscopic Radical Prostatectomy with Robotics Pelvic Lymphadenectomy Positron Emission Tomography Relugolix

Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer

This clinical trial evaluates the use of an imaging scan (18F-rhPSMA-7.3 po...

Status

Recruiting

Location

Mayo Clinic in Florida

Start Date

2024-06-11

Trial ID

NCT06389786

Treatments Being Tested

Bilateral Pelvic Lymph Node Dissection Biospecimen Collection Bone Scan Computed Tomography Electronic Health Record Review Flotufolastat F-18 Gallium Laparoscopic Radical Prostatectomy with Robotics Magnetic Resonance Imaging Positron Emission Tomography

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

PHASE1

This phase I trial tests the safety, side effects and best dose of radiolig...

Status

Active Not Recruiting

Location

Emory University Hospital/Winship Cancer Institute

Start Date

2023-11-29

Trial ID

NCT06105918

Treatments Being Tested

Biospecimen Collection Computed Tomography External Beam Radiation Therapy Flotufolastat F-18 Lutetium Lu 177 PSMA-10.1 Positron Emission Tomography Single Photon Emission Computed Tomography

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

N/A

The purpose of this study is to assess detection rate of flotufolastat F 18...

Status

Recruiting

Location

Massachusetts General Hospital

Start Date

2025-05-20

Trial ID

NCT06862856

Treatments Being Tested

Positron Emission Tomography (PET)

An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.

PHASE2

This phase II trial evaluates how well flotufolastat F 18 positron emission...

Status

Recruiting

Location

UCLA / Jonsson Comprehensive Cancer Center

Start Date

2025-10-09

Trial ID

NCT07185165

Treatments Being Tested

Computed Tomography Fluorine F 18 Flotufolastat Positron Emission Tomography Ultrasound-Guided Prostate Biopsy

Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance

PHASE2

This investigator-initiated, prospective study evaluates the diagnostic uti...

Status

Recruiting

Location

Mount Sinai Hospital / Icahn School of Medicine at Mount Sinai

Start Date

2026-02-10

Trial ID

NCT07285057

Treatments Being Tested

rhPSMA-7.3 (18F) PET/CT Imaging (Flotufolastat F18, POSLUMA®)Flotufolastat F18

POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions

PHASE2

The goal of this study to determine if using the (18)F-rhPSMA-7.3 PET-CT sc...

Status

Recruiting

Location

UF Health - Jacksonville

Start Date

2025-11-04

Trial ID

NCT07220720

Treatments Being Tested

Flotufolastat F 18

Previous Next